Research & IP · Australia

Clarity Pharmaceuticals

Develops copper-64/copper-67 theranostic pairs (SAR-bisPSMA, SARTATE) in late-stage clinical trials.

Headquarters
Sydney, Australia · Oceania
Value chain
Research & IP(Research & design)
What that means
Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
Founded
2010
Ownership
Listed
Listing
ASX:CU6 on Google Finance
Website
claritypharmaceuticals.com
Relevance
Moderate at its strongest, in Nuclear Medicine & Radioisotope Technologies

In 1 capability

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Design · listed #34 of 50

    Develops copper-64/copper-67 theranostic pairs (SAR-bisPSMA, SARTATE) in late-stage clinical trials.

    Relevance: Copper theranostics developer

    Source · claritypharmaceuticals.com